Abstract:DOI:10.1097/MOL.0b013e3283555a9c Atherosclerosis is characterized by chronic inflammation of the arterial wall, mediated by adhesion and secretion of activated platelets, neutrophils and monocytes, as well as T cells and dendritic cells infiltrating the vascular lesion [1 && ,2]. Investigation of new targets will advance our understanding about cellular dynamics in the pathophysiology of atherosclerosis and will enable development of diagnostic and early therapy approaches for prevention and treatment of cardiovascular disease. Oxidatively modified LDL (oxLDL) confer lysophosphatidylcholine, which is the main substrate for generation of lysophosphatidic acid (LPA) by autotaxin during atherogenesis [3 && ,4]. Recently, Zhou et al. [3 && ] investigated the role of LPA in lipoprotein-induced monocyte recruitment and atherosclerosis. Interestingly, unsaturated LPA promoted plaque progression, macrophage accumulation and leukocyte recruitment to the vessel wall during early atherosclerosis [3 && ,5], mediating oxLDL-induced monocyte adhesion through the CXCL1/CXCR2 chemokine axis and endothelial LPA receptors. Of interest, LPA2 expression is downregulated, whereas LPA1 and LPA3 are expressed in lesional endothelial cells. In line with these observations, blocking the LPA receptors LPA1 and LPA3 reduced hyperlipidemia-induced leukocyte arrest and macrophage accumulation through CXCL1, which sequentially reduced atherosclerosis. Thus, the identification of endothelial LPA receptors and their functions may offer new perspectives for therapeutic interventions. Furthermore, other known sources of LPA precursors are, for instance, activated platelets [4], whose role clearly extends beyond hemostasis and thrombosis [1 && ,6]. Notably, Postea et al. [7] recently discovered the involvement of CX3CL1 chemokine and its receptor CX3CR1 in platelet–monocyte complex (PMC) formation and monocyte recruitment during atherosclerosis. Moreover, human and mouse platelets overexpressed CX3CR1, which was implicated with an

The synergistic mechanisms of oxidized phospholipids and lipoprotein-associated phospholipase A2 associated with Lp ( a ) in promoting atherosclerosis

Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis

Study on relationship of lipoprotein-associated phospholipase A2 expression and atherosclerosis progression

Role of phospholipid oxidation products in atherosclerosis

Dietary Sterols and Sterol Oxidation Products on Atherosclerosis: an Insight Provided by Liver Proteomic and Lipidomic.

Atherosclerosis: cell biology and lipoproteins--new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells.

Lipoprotein(a) in atherosclerotic cardiovascular disease and proprotein convertase subtilisin/kexin-type 9 inhibitors

Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process

The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy

Elevated concentrations of oxidized lipoprotein(a) are associated with the presence and severity of acute coronary syndromes.

Lipoprotein-Associated Phospholipase A 2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults

The functions of apolipoproteins and lipoproteins in health and disease

Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease

Possible non-classic intracellular and molecular mechanisms of LDL cholesterol action contributing to the development and progression of atherosclerosis

Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular Outcomes: Prospective Results from the Bruneck Study

Progress in Lecin-Like Oxidized LDL Receptor-1 As a Novel Therapeutic Target in Atherosclerotic Cardiovascular Diseases

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

Platelets as an inter‐player between hyperlipidaemia and atherosclerosis

Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies

LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment